Thalidomide Pharmacokinetics and Metabolite Formation in Mice, Rabbits, and Multiple Myeloma Patients
CHUNG, Francisco, JUN LU, PALMER, Brian D, KESTELL, Philip, BROWETT, Peter, BAGULEY, Bruce C, TINGLE, Malcolm, CHING, Lai-Ming
Published in Clinical cancer research (01.09.2004)
Published in Clinical cancer research (01.09.2004)
Get full text
Journal Article
Mechanisms by which resistant starches and non-starch polysaccharide sources affect the metabolism and disposition of the food carcinogen, 2-amino-3-methylimidazo[4,5- f]quinoline
Kestell, P., Zhu, S., Ferguson, L.R.
Published in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (25.03.2004)
Published in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (25.03.2004)
Get full text
Journal Article
Pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (AS1404), a novel vascular disrupting agent, in phase I clinical trial
JAMESON, M. B, BAGULEY, B. C, KESTELL, P, ZHAO, L, PAXTON, J. W, THOMPSON, P. I, WALLER, S
Published in Cancer chemotherapy and pharmacology (01.04.2007)
Published in Cancer chemotherapy and pharmacology (01.04.2007)
Get full text
Journal Article
Thalidomide Metabolites in Mice and Patients with Multiple Myeloma
JUN LU, PALMER, Brian D, KESTELL, Phillip, BROWETT, Peter, BAGULEY, Bruce C, MULLER, George, CHING, Lai-Ming
Published in Clinical cancer research (01.05.2003)
Get full text
Published in Clinical cancer research (01.05.2003)
Journal Article
Reversible binding of the novel anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid to plasma proteins and its distribution into blood cells in various species
Zhou, S, Paxton, J W, Kestell, P, Tingle, M D
Published in Journal of pharmacy and pharmacology (01.04.2001)
Published in Journal of pharmacy and pharmacology (01.04.2001)
Get more information
Journal Article
Modulation of thalidomide pharmacokinetics by cyclophosphamide or 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice: the role of tumour necrosis factor
CHUNG, Francisco, WANG, Liang-Chuan S, KESTELL, Philip, BAGULEY, Bruce C, CHING, Lai-Ming
Published in Cancer chemotherapy and pharmacology (01.05.2004)
Published in Cancer chemotherapy and pharmacology (01.05.2004)
Get full text
Journal Article
Transport of thalidomide by the human intestinal Caco-2 monolayers
SHUFENG ZHOU, YAN LI, KESTELL, Phillip, SCHAFER, Peter, CHAN, Eli, PAXTON, James W
Published in European journal of drug metabolism and pharmacokinetics (01.01.2005)
Published in European journal of drug metabolism and pharmacokinetics (01.01.2005)
Get full text
Journal Article
Identification and reactivity of the major metabolite (ß-1-glucuronide) of the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in humans
Zhou, S. F., Paxton, J. W., Tingle, M. D., Kestell, P., Jameson, M. B., Thompson, P. I., Baguley, B. C.
Published in Xenobiotica (01.05.2001)
Published in Xenobiotica (01.05.2001)
Get full text
Journal Article
Metabolism and elimination of 5,6-dimethylxanthenone-4-acetic acid in the isolated perfused rat liver
Webster, L K, Ellis, A G, Kestell, P, Rewcastle, G W
Published in Drug metabolism and disposition (01.03.1995)
Get more information
Published in Drug metabolism and disposition (01.03.1995)
Journal Article
Effect of 3-fluorothalidomide and 3-methylthalidomide enantiomers on tumor necrosis factor production and antitumor responses to the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)
Chung, Francisco, Palmer, Brian D, Muller, George W, Man, Hon-Wah, Kestell, Phillip, Baguley, Bruce C, Ching, Lai-Ming
Published in Oncology research (2003)
Published in Oncology research (2003)
Get more information
Journal Article
Light-induced breakdown of flavone acetic acid and xanthenone analogues in solution
Rewcastle, G W, Kestell, P, Baguley, B C, Denny, W A
Published in JNCI : Journal of the National Cancer Institute (21.03.1990)
Published in JNCI : Journal of the National Cancer Institute (21.03.1990)
Get more information
Journal Article
5,6-Dimethylxanthenone-4-Acetic Acid in the Treatment of Refractory Tumors: a Phase I Safety Study of a Vascular Disrupting Agent
MCKEAGE, Mark J, FONG, Peter, JEFFERY, Mark, BAGULEY, Bruce C, KESTELL, Phil, RAVIC, Miroslav, JAMESON, Michael B
Published in Clinical cancer research (15.03.2006)
Published in Clinical cancer research (15.03.2006)
Get full text
Journal Article